MCW Pancreatic Cancer Clinical Symposium
Pancreatic cancer is increasing in incidence and will become the second leading cause of cancer-related deaths by 2020. This symposium brings together experts in the area of pancreatic cancer to provide the most up-to-date information on the diagnosis, staging, and state-of-the-art treatments for pancreatic cancer.
MCW Pancreatic Cancer Clinical Symposium will be held Friday, Janruary 31, 2020 from 8 a.m. to 4 p.m. in the Rumble Room of the Harley-Davidson Museum at 400 W. Canal Street, Milwaukee, WI 53201.
• Primary care physicians
• General surgeons
• Medical oncologists
• Radiation oncologists
1. To define the diagnostic studies needed to accurately stage pancreatic cancer patients.
2. Review multimodality stage-specific treatment sequencing based on clinical stage for patients with pancreatic cancer.
3. Review current controversies in the management of locally advanced and localized pancreatic cancer
8:00 AM: Registration Opens/Breakfast available
8:20-8:55 AM: Meet the Professor (optional session before the symposium begins, please pre-register for one if you plan to attend)
- Section I: Dr. Wang-Gilliam, Bolt Room
- Section II: Dr. Hong, Potato Room
- Section III: Dr. Christians, Rumble Room
9:00-9:30 AM: Fundamentals of Radiographic Staging of Pancreatic Cancer | Stacy O’Connor, MD, MPH, MMS
9:30-10:00 AM: Endoscopic Management of Pancreatic Cancer | Phillip Chisholm, MD
10:00-10:30 AM: Neoadjuvant Treatment Sequencing for Resectable and Borderline Resectable Pancreatic Cancer | Douglas Evans, MD
10:30-11:00 AM: Identification and Treatment of Sleep Problems in Pancreatic Cancer Patients | Karen Kersting, PhD, LCP
11:00-11:15 PM: Break
11:15-12:00 PM: Neoadjuvant Therapy for Pancreatic Cancer: Treatment Paradigms and the Role of Radiation Therapy | Theodore Hong, MD
12:00-12:20 PM: Questions/Break
12:20-1:15 PM: Tumor Board over Lunch | Susan Tsai, MD, MHS
1:15-1:45 PM: Advances in Image Guided and Personalized Radiotherapy For Pancreatic Cancer, A New Frontier | William Hall, MD
1:45-2:15 PM: Surgical Nuances in Pancreatic Cancer | Kathleen Christians, MD
2:15-3:00 PM: Novel Therapeutic Development in Pancreatic Cancer | Andrea Wang-Gillam, MD, PhD
3:00-3:20 PM: Questions/Break
3:20- 3:50 PM: GI ASCO Update/Clinical Trials for Advanced Pancreatic Cancer | Ben George, MD
3:50-4:00 PM: Wrap Up and Review of Upcoming CME Events/Pancreatic Cancer Program Initiatives
Free parking is located onsite.
Andrea Wang-Gillam MD, PhD
Associate Professor of Medicine
Director, Developmental Therapeutics Program
Clinical Director, Gastrointestinal Oncology Program
Division of Oncology, Section of Medical Oncology
Washington University in St.Louis
Theodore Sunki Hong, MD
Professor, Radiation Oncology Harvard Medical School
Director, Gastrointestinal Service, Department of Radiation Oncology
Associate Clinical Director, Department of Radiation Oncology
Massachusetts General Hospital
Stacy O’Connor, MD, MPH, MMS
Assistant Professor, Division of Radiology
Phillip Chisholm, MD
Assistant Professor, Department of Medicine, Division of Gastroenterology
Kathleen Christians, MD
Professor, Division of Surgical Oncology
Douglas Evans, MD
Donald C. Ausman Family Foundation Professor in Surgery and Chair
Ben George, MD
Assistant Professor, Division of Hematology and Medical Oncology
William Hall, MD
Associate Professor, Division of Radiation Oncology
Karen Kersting, PhD, LCP
Assistant Professor, Division of Surgical Oncology
Susan Tsai, MD, MHS
Associate Professor, Division of Surgical Oncology
All persons in control of content have NO relevant financial relationships to disclose except:
|Ted Hong, MD||Merck, Synthetic Biologies, Novocure, AstraZeneca, Taiho, IntraOp, BMS, TESARO||Advisory Board, Consultant, DSMB, Principal Investigator|
|Andrea Wang-Gillian||Jacobio Pharmaceuticals, Tyme Inc., Astrazeneca||Consultant|
In accordance with the ACCME® Standards for Commercial Support Number 6, all in control of content disclosed any relevant financial relationships. These relationships were reviewed via the MCW conflict of interest resolution process and resolved.
ACCME ACCREDITATION STATEMENT
The Medical College of Wisconsin is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
AMA CREDIT DESIGNATION STATEMENT
The Medical College of Wisconsin designates this live activity for a maximum of 6.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
HOURS OF PARTICIPATION FOR ALLIED HEALTH CARE PROFESSIONALS
The Medical College of Wisconsin designates this activity for up to 6.5 hours of participation for continuing education for allied health professionals.
- 6.50 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 6.50 Hours of ParticipationHours of Participation credit.
Register at ocpe.mcw.edu/surgery. If you don’t have an account, click “Create New Visitor Account” in the lower right corner. Once your account is created, select MCW PANCREATIC CANCER CLINICAL SYMPOSIUM under “Featured Courses,” register, and follow the prompts.
If requesting CE credit, a $25 registration fee will be assessed during check out. For those not claiming CE credit, please select the appropriate option during checkout and there will be no fee.
Refund Policy: Cancellations must be received in writing. Cancellations postmarked January 24 and earlier will be fully refunded. No refunds are available for cancellations postmarked after January 24.
PLEASE NOTE! The billing address entered upon checkout must match the billing address on the credit card you will be using to pay for this course. MCW accepts MasterCard, VISA and Discover card.
Please note: Google Chrome and Mozilla Firefox are the preferred browsers.